ALINIDINE BIOTRANSFORMATION IN HEALTHY SUDANESE ARABSHARRON DWG; ARNDTS DE; SHANKS RG et al.1982; INTERNATIONAL JOURNAL OF PHARMACEUTICS; ISSN 0378-5173; NLD; DA. 1982; VOL. 12; NO 4; PP. 277-283; BIBL. 8 REF.Article

ALINIDINE PHARMACOKINETICS FOLLOWING ACUTE AND CHRONIC DOSINGHARRON DWG; ARNDTS D; SHANKS RG et al.1982; BR. J. CLIN. PHARMACOL.; ISSN 0306-5251; GBR; DA. 1982; VOL. 13; NO 6; PP. 821-827; BIBL. 9 REF.Article

DEBENDOX AND CONGENITAL MALFORMATIONS IN NORTHERN IRELANDHARRON DWG; GRIFFITHS K; SHANKS RG et al.1980; BR. MED. J.; ISSN 0007-1447; GBR; DA. 1980; VOL. 281; NO 6252; PP. 1379-1381; BIBL. 10 REF.Article

CARDIOVASCULAR EFFECTS OF ALINIDINE AND PROPRANOLOL ALONE AND IN COMBINATION WITH HYDRALAZINE IN NORMAL MANNICHOLLS DP; HARRON DWG; SHANKS RG et al.1983; BRITISH JOURNAL OF CLINICAL PHARMACOLOGY; ISSN 0306-5251; GBR; DA. 1983; VOL. 15; NO 1; PP. 21-29; BIBL. 26 REF.Article

CARDIOVASCULAR EFFECTS OF INDORAMIN IN MAN: A DOSE RANGING STUDYNICHOLLS DP; HARRON DWG; SHANKS RG et al.1983; BRITISH JOURNAL OF CLINICAL PHARMACOLOGY; ISSN 0306-5251; GBR; DA. 1983; VOL. 15; NO 1; PP. 31-36; BIBL. 2 P.Article

CARDIOVASCULAR EFFECTS OF ALINIDINE (ST567) IN HEALTHY VOLUNTEERSHARRON DWG; RIDDELL JG; SHANKS RG et al.1981; BR. J. CLIN. PHARMACOL.; ISSN 0306-5251; GBR; DA. 1981; VOL. 11; NO 1; PP. 116P-117P; BIBL. 2 REF.Article

CAN DIGOXIN PRESCRIBING BE IMPROVED. A COMPARISON BETWEEN INTUITIVE AND ASSISTED DOSE SELECTIONJOHNSTON GD; HARRON DWG; MCDEVITT DG et al.1979; EUROP. J. CLIN. PHARMACOL.; DEU; DA. 1979; VOL. 16; NO 4; PP. 229-235; BIBL. 30 REF.Article

DIGOXIN DISTRIBUTION BETWEEN PLASMA AND MYOCARDIUM IN HYPOXIC AND NON-HYPOXIC DOGSHARRON DWG; SWANTON JG; COLLIER PS et al.1982; EXPERIENTIA; ISSN 0014-4754; CHE; DA. 1982; VOL. 38; NO 7; PP. 839-841; BIBL. 13 REF.Article

EFFECT OF ALINIDINE ON EXPERIMENTAL CARDIAC ARRHYTHMIASHARRON DWG; ALLEN JD; WILSON R et al.1982; J. CARDIOVASC. PHARMACOL.; ISSN 0160-2446; USA; DA. 1982; VOL. 4; NO 2; PP. 221-225; BIBL. 27 REF.Article

INTERACTION OF DIGOXIN WITH ACTIVATED DIMETHICONE AND OTHER ANTACID CONSTITUENTSMCELNAY JC; HARRON DWG; D'ARCY PF et al.1979; EXPERIENTIA; CHE; DA. 1979; VOL. 35; NO 1; PP. 94; BIBL. 6 REF.Article

THE INTERACTION OF WARFARIN WITH ANTACID CONSTITUENTS IN THE GUTMCELNAY JC; HARRON DWG; D'ARCY PF et al.1979; EXPERIENTIA; CHE; DA. 1979; VOL. 35; NO 10; PP. 1359-1360; BIBL. 12 REF.Article

AN "IN VITRO" SYSTEM FOR THE CORRELATION OF DRUG/PROTEIN BINDING WITH VARIABLE PLASMA PROTEIN PROFILE.HARRON DWG; MCELNAY JC; D'ARCY PF et al.1978; INTERNATION. J. PHARMACEUT.; NETHERL.; DA. 1978; VOL. 1; NO 1; PP. 61-64; BIBL. 10 REF.Article

COMPARISON OF THE BETA -ADRENOCEPTOR BLOCKING ACTIVITY OF OXPRENOLOL, SLOW RELEASE OXPRENOLOL AND A COMBINED OXPRENOLOL DIURETIC PREPARATIONKERR MJ; HARRON DWG; KINNEY C et al.1981; BR. J. CLIN. PHARMACOL.; ISSN 0306-5251; GBR; DA. 1981; VOL. 12; NO 6; PP. 869-871; BIBL. 12 REF.Article

EFFECTS ON EXERCICE TACHYCARDIA DURING FORTY-EIGHT HOURS OF A SERIES OF DOSES OF ATENOLOL, SOTALOL, AND METOPROLOLHARRON DWG; BALNAVE K; KINNEY CD et al.1981; CLIN. PHARMACOL. THER.; ISSN 0009-9236; USA; DA. 1981; VOL. 29; NO 3; PP. 295-302; BIBL. 15 REF.Article

COMPARATIVE PHARMACOLOGICAL AND PHARMACOKINETIC OBSERVATIONS ON PROPRANOLOL (LONG ACTING FORMULATION) AND BENDROFLUAZIDE ADMINISTERED SEPARATELY AND CONCURRENTLY TO VOLUNTEERSNICHOLLS DP; HARRON DWG; MCAINSH J et al.1982; BR. J. CLIN. PHARMACOL.; ISSN 0306-5251; GBR; DA. 1982; VOL. 14; NO 5; PP. 727-732; BIBL. 20 REF.Article